Is Abbott India technically bullish or bearish?

Current Technical Landscape

As of 2 December 2025, Abbott India’s technical trend has shifted from mildly bearish to outright bearish, signalling a deterioration in market sentiment. The stock closed at ₹29,240, down from the previous close of ₹29,818.80, reflecting a short-term weakness. The intraday range on the day saw a high of ₹29,899.85 and a low of ₹29,129.15, indicating some volatility but no decisive upward momentum.

The 52-week price range remains broad, with a high of ₹35,921.55 and a low of ₹25,260.20, underscoring the stock’s capacity for significant swings. However, the current price is closer to the lower end of this range, which may be a concern for momentum traders.

Momentum Indicators Paint a Bearish Picture

Several widely followed technical indicators are signalling bearish momentum. The Moving Average Convergence Divergence (MACD) is bearish on the weekly chart and mildly bearish on the monthly, suggesting that the stock’s medium-term momentum is weakening. Similarly, the Bollinger Bands indicate bearish conditions on both weekly and monthly timeframes, implying that the stock price is trending towards the lower band, often a sign of downward pressure.

Daily moving averages also confirm a bearish stance, reinforcing the view that the stock is under selling pressure in the short term. The Know Sure Thing (KST) indicator, which aggregates multiple momentum signals, is bearish weekly and mildly bearish monthly, further supporting the negative momentum thesis.

Contrasting Signals from Oscillators and Volume

Not all technical signals are negative. The Relative Strength Index (RSI) on the weekly chart is bullish, indicating that the stock may not be oversold and could have some underlying strength. However, the monthly RSI shows no clear signal, suggesting a lack of conviction in longer-term momentum.

Volume-based indicators such as On-Balance Volume (OBV) are mildly bullish on the weekly timeframe, hinting that accumulation might be occurring despite price weakness. Dow Theory analysis also shows a mildly bullish weekly signal, though no trend is established monthly. These mixed signals imply that while selling pressure dominates, some investors may be positioning for a potential rebound or consolidation.

Comparative Performance Against Sensex

Abbott India’s recent returns relative to the benchmark Sensex index provide additional context to its technical outlook. Over the past week, the stock has declined by 3.42%, while the Sensex gained 0.65%, highlighting short-term underperformance. Over one month, Abbott India’s return is a modest 0.82%, trailing the Sensex’s 1.43% gain.

Year-to-date, the stock is down 1.46%, contrasting with the Sensex’s robust 8.96% advance. Over the past year, Abbott India has delivered a 4.17% return, slightly below the Sensex’s 6.09%. However, the longer-term picture is more favourable: over three years, Abbott India has outperformed the Sensex with a 44.79% gain versus 35.42%, and over five years, it has marginally surpassed the benchmark with a 92.17% return compared to 90.82%.

Most notably, the ten-year return of 469.07% dwarfs the Sensex’s 225.98%, underscoring the company’s strong fundamental growth and resilience over the long haul. This long-term outperformance may provide some comfort to investors despite the current technical weakness.

Price Action and Volatility Considerations

Abbott India’s price action in recent sessions has been characterised by a downward drift from the previous close, with the stock failing to sustain intraday highs near ₹29,900. The proximity to the 52-week low of ₹25,260.20 suggests that the stock is vulnerable to further downside if bearish momentum persists.

Volatility remains elevated, as evidenced by the intraday price range exceeding ₹700, which may deter risk-averse investors. The bearish signals from moving averages and Bollinger Bands imply that the stock could continue to test lower support levels in the near term.

Technical Outlook: Bearish Bias with Cautious Bullish Hints

Overall, the technical evidence points to a bearish bias for Abbott India at present. The shift from mildly bearish to bearish trend status, combined with negative MACD, moving averages, and Bollinger Bands, suggests that sellers currently dominate the market. The weekly RSI and OBV mild bullishness offer some counterbalance, indicating that a short-term bounce or consolidation phase cannot be ruled out.

Investors should monitor key support levels near the recent lows and watch for any reversal patterns or volume spikes that could signal a change in trend. Given the mixed signals, a cautious approach is advisable, with attention to broader market conditions and sectoral trends in pharmaceuticals and biotechnology.

Investor Takeaway

For investors considering Abbott India, the current technical landscape advises prudence. The dominant bearish signals suggest that the stock may face further downward pressure in the short to medium term. However, the company’s strong long-term fundamentals and historical outperformance relative to the Sensex provide a foundation for potential recovery once selling pressure abates.

Those with a higher risk tolerance might look for signs of technical reversal or accumulation before initiating new positions. Conversely, investors seeking less volatile or more clearly bullish opportunities may prefer to explore alternative stocks within the pharmaceuticals and biotechnology sector, especially those exhibiting stronger momentum and trend confirmation.

In summary, Abbott India is technically bearish at present, but the presence of some bullish indicators warrants close monitoring for any shifts in market dynamics.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →